Association of defective HLA-I expression with antigen processing machinery and their association with clinicopathological characteristics in Kazak patients with esophageal cancer

Chinese Medical Journal

Volumn 124, Issue 3, 2011, Pages 341-346

  Hasim, Ayshamgul ^a   Ma, Hong ^a   Sheyhidin, Ilyar ^a   Zhang, Li Wei ^a   Abudula, Abulizi ^a  

^a XINJIANG MEDICAL UNIVERSITY   (China)

Author keywords

Antigen processing machinery; Human leukocyte antigen class I; Human papillomavirus; Kazak's esophageal cancer

Indexed keywords

CALNEXIN; ENDOPLASMIC RETICULUM AMINO PEPTIDASE ASSOCIATED WITH ANTIGEN PRESENTATION 1; HLA ANTIGEN CLASS 1; LOW MOLECULAR MASS PROTEIN 7; MEMBRANE PROTEIN; PROTEIN ERP57; TAPASIN; TRANSPORTER ASSOCIATED WITH ANTIGEN PROCESSING 1; UNCLASSIFIED DRUG; VIRUS DNA;

ADULT; ANTIGEN EXPRESSION; ANTIGEN PRESENTATION; ARTICLE; CANCER GRADING; CANCER INVASION; CANCER TISSUE; CHINA; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DOWN REGULATION; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; ETHNIC GROUP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; PAPILLOMAVIRUS INFECTION; PATHOPHYSIOLOGY; POLYMERASE CHAIN REACTION; PROGNOSIS; PROTEIN ANALYSIS; PROTEIN DEPLETION; VIRUS DETECTION; WART VIRUS;

ADULT; AGED; AMINOPEPTIDASES; ANTIGEN PRESENTATION; ATP-BINDING CASSETTE TRANSPORTERS; CALNEXIN; ESOPHAGEAL NEOPLASMS; FEMALE; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMAN PAPILLOMAVIRUS 16; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MEMBRANE TRANSPORT PROTEINS; MIDDLE AGED; POLYMERASE CHAIN REACTION; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTEIN DISULFIDE-ISOMERASES;

EID: 79551702601     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0366-6999.2011.03.004     Document Type: Article

References (22)

1. Tytgat GN, Bartelink H, Bernards R, Giaccone G, van Lanschot JJ, Offerhaus GJ, et al. Cancer of the esophagus and gastric cardia: recent advances. Dis Esophagus 2004; 17: 10-26.
2. Zhang Y. The distribution of esophageal cancer in Xinjiang. J Xinjiang Med Univ (Chin) 1988; 11: 139-144.
3. Lu XM, Monnier-Benoit S, Mo LZ, Xu SY, Prétet JL, Liu Z, et al. Human papillomavirus in esophageal squamous cell carcinoma of the high-risk Kazakh ethnic group in Xinjiang, China. Eur J Surg Oncol 2008; 34: 765-770.
4. de Boer M, Jordanova E, van Poelgeest M, van den Akker B, van der Burg S, Kenter G, et al. Circulating human papillomavirus type 16 specific T-cells are associated with HLA class I expression on tumor cells, but not related to the amount of viral oncogene transcripts. Int J Cancer 2007; 121: 2711-2715.
5. Breitburd F, Ramoz N, Salmon J, Orth G. HLA control in the progression of human papillomavirus infections. Semin Cancer Biol 1996; 7: 359-371.
6. Natarajan K, Li H, Mariuzza R, Margulies D. MHC class I molecules, structure and function. Rev Immunogenet 1999; 1: 32-46.
7. Paulsson K. Evolutionary and functional perspectives of the major histocompatibility complex class I antigen-processing machinery. Cell Mol Life Sci 2004; 61: 2446-2460.
8. Zhang Y, Williams DB. Assembly of MHC class I molecules within the endoplasmic reticulum. Immunol Res 2006; 34 (1-2): 151-162.
9. Seliger B, Ritz U, Ferrone S. Molecular mechanisms of HLA class I antigen abnormalities following viral infection and transformation. Int J Cancer 2006; 118: 129-138.
10. Gromme M, Neefjes J. Antigen degradation or presentation by MHC class I molecules via classical and non-classical pathways. Mol Immunol 2002; 39: 181-202.
11. York IA, Chang SC, Saric T, Keys JA, Favreau JM, Goldberg AL, et al. The ER aminopeptidase ERAP1 enhances or limits antigen presentation by trimming epitopes to 8-9 residues. Nat Immunol 2002; 3: 1177-1184.
12. Meissner M, Reichert TE, Kunkel M, Gooding W, Whiteside TL, Ferrone S, et al. Defects in the human leukocyte antigen class I antigen-processing machinery in head and neck squamous cell carcinoma: association with clinical outcome. Clin Cancer Res 2005; 11: 2552-2560.
13. Cathro HP, Smolkin ME, Theodorescu D, Jo VY, Ferrone S, Frierson HF Jr. Relationship between HLA class I antigen processing machinery component expression and the clinicopathologic characteristics of bladder carcinomas. Cancer Immunol Immunother 2010; 59: 465-472.
14. Ramnath N, Tan D, Li Q, Hylander BL, Bogner P, Ryes L, et al. Is down-regulation of MHC class I antigen expression in human non-small cell lung cancer associated with prolonged survival. Cancer Immunol Immunother 2006; 55: 891-899.
15. Han LY, Fletcher MS, Urbauer DL, Mueller P, Landen CN, Kamat AA, et al. HLA class I antigen processing machinery component expression and intratumoral T-cell infiltrate as independent prognostic markers in ovarian carcinoma. Clin Cancer Res 2008; 14: 3372-3379.
16. Hazelbag S, Gorter A, Kenter GG, vanden Broek L, Fleuren GJ. Transforming growth factor-beta1 induces tumour stroma and reduces tumour in filtrate in cervical cancer. Hum Pathol 2002; 33: 1193-1199.
17. Liu Q, Hao C, Su P, Shi J. Down-regulation of HLA class I antigen-processing machinery components in esophageal squamous cell carcinomas: association with disease progression. Scand J Gastroenterol 2009; 44: 960-969.
18. Mizukami Y, Kono K, Maruyama T, Watanabe M, Kawaguchi Y, Kamimura K, et al. Down-regulation of HLA class I molecules in the tumour is associated with a poor prognosis in patients with oesophageal squamous cell carcinoma. Br J Cancer 2008; 99: 1462-1467.
19. Manning J, Indrova M, Lubyova B, Pribylova H, Bieblova J, Hejnar J, et al. Induction of MHC class I molecule cell surface expression and epigenetic activation of antigen-processing machinery components in a murine model for human papillomavirus 16-associated tumors. Immunology 2007; 123: 218-227.
20. Garrido F, Ruiz-Cabello F, Cabrera T, Perez-Villar J, Lopez-Botet M, Duggan-Keen M, et al. Implications for immunosurveillance of altered HLA class I phenotypes in human tumors. Immunol Today 1997; 18: 89-95.
21. Mehta AM, Jordanova ES, Kenter GG, Ferrone S, Fleuren GJ. Association of antigen processing machinery and HLA class I defects with clinicopathological outcome in cervical carcinoma. Cancer Immunol Immunother 2008; 57: 197-206.
22. Ogino T, Shigyo H, Ishii H, Katayama A, Miyokawa N, Harabuchi Y, et al. HLA class I antigen down-regulation in primary laryngeal squamous cell carcinoma lesions as a poor prognostic marker. Cancer Res 2006; 66: 9281-9289.